Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma

被引：0
|
作者：
Wang, Zhengxin [1 ]
Yang, Jiayin [2 ]
Li, Guangming [3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Organ Transplantat Inst, Liver Transplantat Ctr,Gen Surg Dept, Shanghai 200040, Peoples R China
[2] Sichuan Univ, West China Hosp, Organ Transplantat Ctr, Chengdu 610044, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Youan Hosp, Liver Transplantat Ctr, Gen Surg Dept, Beijing 100069, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 18期
基金：
北京市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2143 / 2145
页数：3
相关论文
共 50 条
  • [31] Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
    Abushukair, Hassan Mohammed
    Saeed, Anwaar
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (06) : 1210 - 1212
  • [32] Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors
    Y. Linda Wu
    Sarah Cappuyns
    Amanda Loh
    Sean Sun
    Sara Lewis
    Max W. Sung
    Myron Schwartz
    Josep M. Llovet
    Deirdre J. Cohen
    BJC Reports, 2 (1):
  • [33] Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
    Yang, Yu
    Sun, Juxian
    Wu, Mengchao
    Lau, Wan Yee
    Zheng, Shusen
    Wang, Xue-Hao
    Chen, Xiaoping
    Fan, Jia
    Dong, Jiahong
    Cai, Jianqiang
    Chen, Minshan
    Chen, Yongjun
    Cheng, Zhangjun
    Dai, Chaoliu
    Shan, Jianzhen
    Du, Cheng-You
    Fang, Chihua
    Hu, Heping
    Ji, Zhili
    Jia, Weidong
    Li, Gong
    Li, Jing
    Li, Jiangtao
    Liu, Chang
    Liu, Fubao
    Ma, Yong
    Mao, Yilei
    Niu, Zuoxing
    Shen, Jie
    Shi, Jie
    Shi, Xuetao
    Song, Wenjie
    Sun, Hui-Chuan
    Tan, Guang
    Tao, Ran
    Wang, Xiaohu
    Wen, Tianfu
    Wu, Liqun
    Xia, Jinglin
    Xiang, Bang-De
    Yan, Maolin
    Ying, Mingang
    Zhang, Ling
    Zhang, Xuewen
    Zeng, Zhao Chong
    Zhang, Yubao
    Zhang, Zhiwei
    Zhou, Jie
    Zhou, Cuncai
    Zhou, Jun
    LIVER CANCER, 2022, 11 (06) : 511 - 526
  • [34] Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
    Hai-Tao Zhao
    Jian-Qiang Cai
    World Journal of Gastroenterology, 2021, 27 (47) : 8069 - 8080
  • [35] Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
    Zhao, Hai-Tao
    Cai, Jian-Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (47) : 8069 - 8080
  • [36] Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
    Nishida, Naoshi
    Kudo, Masatoshi
    CANCERS, 2020, 12 (05)
  • [37] Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition)
    Sun Juxian
    Li Qiu
    Bai Xueli
    Cai Jianqiang
    Chen Yajin
    Chen Minshan
    Dai Chaoliu
    Fang Chihua
    Jia Weidong
    Li Xiangcheng
    Wen Tianfu
    Xia Jinglin
    Ying Mingang
    Zhang Zhiwei
    Zhang Xuewen
    Zeng Zhaochong
    Cheng Shuqun
    中华医学杂志英文版, 2024, 137 (21)
  • [38] Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition)
    Sun, Juxian
    Li, Qiu
    Bai, Xueli
    Cai, Jianqiang
    Chen, Yajin
    Chen, Minshan
    Dai, Chaoliu
    Fang, Chihua
    Jia, Weidong
    Li, Xiangcheng
    Wen, Tianfu
    Xia, Jinglin
    Ying, Mingang
    Zhang, Zhiwei
    Zhang, Xuewen
    Zeng, Zhaochong
    Cheng, Shuqun
    CHINESE MEDICAL JOURNAL, 2024, 137 (21) : 2630 - 2632
  • [39] Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
    Qin, Ran
    Jin, Tianqiang
    Xu, Feng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
    Zeng, Zhu
    Yang, Biao
    Liao, Zheng-Yin
    ONCOLOGY LETTERS, 2020, 20 (04)
12345